4//SEC Filing
Kalif Eliyahu Sharon 4
Accession 0000950170-25-011059
CIK 0000818686other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:01 PM ET
Size
5.9 KB
Accession
0000950170-25-011059
Insider Transaction Report
Form 4
Kalif Eliyahu Sharon
EVP, Chief Financial Officer
Transactions
- Award
Restricted Share Units
2025-01-28+183,169→ 183,169 total→ Ordinary Shares (183,169 underlying)
Footnotes (3)
- [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F2]Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 4, 2025.
- [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001798443
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 4:01 PM ET
- Size
- 5.9 KB